Business Line
Mumbai, May 13 With four overseas acquisitions in three years, Ahmedabad-headquartered Veeda Clinical Research is now close to acquiring an oncology-focused clinical research organisation (CRO) in the US, through its subsidiary Veeda Oncology.
The CRO in US has been identified and the deal is likely to be sealed in the next two to four weeks, Mr Binoy Gardi, Founder and Group Managing Director of Veeda CR, told Business Line. This would be the fifth overseas acquisition between Veeda CR and its oncology subsidiary, after having undertaken similar acquisitions in the United Kingdom (2005), Belgium (2006), Germany (2007) and France, earlier this year.
src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
Post a Comment